NABUFIT Announces Operational Update and Reaching more than 200,000 downloads
Oct 20, 2016 11:01 am UTC| Business
OREM, Utah, Oct. 20, 2016 -- NABUFIT Global ApS, the wholly owned Danish subsidiary of NABUFIT Global, Inc. (OTCQB:NBFT), a ground breaking new training portal that enhances your workout by providing expert advice from...
NewLink Genetics to Webcast 2016 Analyst and Investor Day on October 25, 2016
Oct 20, 2016 11:01 am UTC| Business
AMES, Iowa, Oct. 20, 2016 -- NewLink Genetics Corporation (NASDAQ:NLNK)today announced that it will webcast its Analyst and Investor Day being held onTuesday, October 25 at the Convene Meeting Center in New York City. ...
NewLink Genetics to Webcast 2016 Analyst and Investor Day on October 25, 2016
Oct 20, 2016 11:01 am UTC| Business
AMES, Iowa, Oct. 20, 2016 -- NewLink Genetics Corporation (NASDAQ:NLNK)today announced that it will webcast its Analyst and Investor Day being held onTuesday, October 25 at the Convene Meeting Center in New York City. ...
Adherium Announces Key Technology Patent Granted in US
Oct 20, 2016 11:01 am UTC| Business
MELBOURNE, Australia, Oct. 20, 2016 -- Adherium Limited (ASX:ADR), a global leader in digital health technologies that address sub-optimal medication use in chronic disease, today announced that the US Patent and...
Adherium Announces Key Technology Patent Granted in US
Oct 20, 2016 11:01 am UTC| Business
MELBOURNE, Australia, Oct. 20, 2016 -- Adherium Limited (ASX:ADR), a global leader in digital health technologies that address sub-optimal medication use in chronic disease, today announced that the US Patent and...
Pool Corporation Reports Record Third Quarter Results and Updates 2016 Earnings Guidance Range
Oct 20, 2016 11:01 am UTC| Business
Highlights Net sales growth of 7% with base business net sales growth of 5% for the quarterOperating income growth of 13% for the quarter, 17% year to dateQ3 2016 diluted EPS increased 14% to $1.03 with year to date...
Oct 20, 2016 11:01 am UTC| Business
WESTLAKE VILLAGE, Calif., Oct. 20, 2016 -- Inspyr Therapeutics, Inc. (OTCQB:NSPX), a biotech company developing a novel prodrug therapeutic for the treatment of cancer, announced that the United States Patent and...